# Is PT-141 Legal? FDA, DEA and WADA Status | PepVault

Source: https://pepvault.app/peptides/pt-141/legal-status

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Peptides](https://pepvault.app/peptides) [PT-141](https://pepvault.app/peptides/pt-141) Legal status

Legal status in the United States

# Is PT-141 legal?

Read November 18, 2026 at FDA, DEA and WADA [Published by PepVault](https://pepvault.app/guides/how-we-research)

PT-141 (bremelanotide) is FDA-approved (Vyleesi, first in 2019), is not a federally controlled substance, and is not named on WADA’s Prohibited List, as of November 18, 2026.

## PT-141 at a glance

| Check | Status, read Nov 18, 2026 |
| --- | --- |
| [FDA approval](https://pepvault.app/peptides/pt-141/legal-status#ls-fda) | Approved (Vyleesi, 2019) |
| [Compounding](https://pepvault.app/peptides/pt-141/legal-status#ls-compounding) | Component of an approved drug (503A condition) |
| [DEA schedule](https://pepvault.app/peptides/pt-141/legal-status#ls-dea) | Not controlled |
| [Sport (WADA)](https://pepvault.app/peptides/pt-141/legal-status#ls-wada) | Not named on the list |

## FDA approval

Bremelanotide, sold on the street as PT-141, is FDA-approved as Vyleesi, since 2019, for one use in premenopausal women.

- ### Vyleesi (injection)

  Approved for low sexual desire that causes marked distress (acquired, generalized hypoactive sexual desire disorder) in premenopausal women; its label says it is not for men or to enhance sexual performance. NDA 210557, first approved June 21, 2019.

  - [Drugs@FDA: Vyleesi, application 210557](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210557), U.S. Food and Drug Administration. Read Nov 18, 2026.
  - [Vyleesi prescribing information on DailyMed](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf), National Library of Medicine (DailyMed). Read Nov 18, 2026.

- [Drugs@FDA: Vyleesi, application 210557](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210557), U.S. Food and Drug Administration. Read Nov 18, 2026.

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=legal-status-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Compounding

Bremelanotide is the active ingredient of an FDA-approved drug (Vyleesi). FDA’s page on bulk drug substances gives three conditions under section 503A for a substance a pharmacy compounds from, and one of them is being a component of an FDA-approved drug product; the 503A and 503B bulks lists don’t name bremelanotide.

The source: “Are components of FDA-approved drug products if an applicable USP or NF monograph does not exist”

- [Bulk Drug Substances Used in Compounding (content current as of March 26, 2026)](https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding), U.S. Food and Drug Administration. Read Nov 18, 2026.
- [Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act (updated May 14, 2026)](https://www.fda.gov/media/94155/download), U.S. Food and Drug Administration. Read Nov 18, 2026.
- [503B Bulk Drug Substances List (content current as of May 16, 2024)](https://www.fda.gov/drugs/human-drug-compounding/503b-bulk-drug-substances-list), U.S. Food and Drug Administration. Read Nov 18, 2026.

## DEA schedule

It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.

- [21 CFR Part 1308, Schedules of Controlled Substances (eCFR, up to date as of November 16, 2026)](https://www.ecfr.gov/current/title-21/chapter-II/part-1308), Electronic Code of Federal Regulations. Read Nov 18, 2026.
- [Controlled Substances, Alphabetical Order (dated November 17, 2026)](https://www.deadiversion.usdoj.gov/schedules/orangebook/c_cs_alpha.pdf), Drug Enforcement Administration, Diversion Control Division. Read Nov 18, 2026.

## Sport (WADA)

The 2026 Prohibited List doesn’t name bremelanotide, and S0, the class for unapproved substances, doesn’t reach an approved drug.

- [World Anti-Doping Code International Standard, Prohibited List 2026 (in effect from January 1, 2026)](https://www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf), World Anti-Doping Agency. Read Nov 18, 2026.

## What this means and doesn’t

This page reports what the agencies’ own pages said about PT-141 in the United States when we read them on November 18, 2026. These are records of regulators, not study evidence; for what the research shows, see the compound page.

It is not legal advice, and it doesn’t cover state laws or other countries, whose rules differ. Agencies change their lists, so each fact carries its date and a link to the page it came from.

## About PT-141

### PT-141

- [PT-141 in the library](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)

### Terms

- [Research use only (RUO)](https://pepvault.app/glossary/research-use-only)
- [Compounded drug](https://pepvault.app/glossary/compounded)
- [Off-label use](https://pepvault.app/glossary/off-label)

## Questions

- ### Is PT-141 FDA approved?

  Bremelanotide, sold on the street as PT-141, is FDA-approved as Vyleesi, since 2019, for one use in premenopausal women.
- ### Is PT-141 a controlled substance?

  It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.
- ### Is PT-141 banned in sport?

  The 2026 Prohibited List doesn’t name bremelanotide, and S0, the class for unapproved substances, doesn’t reach an approved drug.
- ### What does FDA say about compounding PT-141?

  Bremelanotide is the active ingredient of an FDA-approved drug (Vyleesi). FDA’s page on bulk drug substances gives three conditions under section 503A for a substance a pharmacy compounds from, and one of them is being a component of an FDA-approved drug product; the 503A and 503B bulks lists don’t name bremelanotide.

## Read next

- [PT-141 in the library](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)
- [Research use only (RUO)](https://pepvault.app/glossary/research-use-only)
- [Compounded drug](https://pepvault.app/glossary/compounded)
- [Off-label use](https://pepvault.app/glossary/off-label)
- [Every compound’s legal status](https://pepvault.app/peptide-legal-status)

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=legal-status-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=legal-status-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=legal-status-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## About PT-141

### PT-141

- [PT-141 in the library](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)

### Terms

- [Research use only (RUO)](https://pepvault.app/glossary/research-use-only)
- [Compounded drug](https://pepvault.app/glossary/compounded)
- [Off-label use](https://pepvault.app/glossary/off-label)

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=legal-status-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## PT-141

- [PT-141 in the library](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)

## Legal status

- [Every compound’s legal status](https://pepvault.app/peptide-legal-status)

## The glossary

- [Research use only (RUO)](https://pepvault.app/glossary/research-use-only)
- [Compounded drug](https://pepvault.app/glossary/compounded)
- [Off-label use](https://pepvault.app/glossary/off-label)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
